The antigenic specificity of purified preparations of A subunit, B subunit, a chain, and y chain of cholera toxin was studied by double immunodiffusion and radioimmunoassay with antisera produced in rabbits and mice. Rabbits immunized with A subunit produced serum antibodies which were capable of binding radiolabeled A subunit, a chain, and B subunit. Rabbits immunized with a chain produced serum antibodies that would bind radiolabeled a chain and A subunit. Rabbits immunized with the B subunit produced serum antibodies monospecific for the B subunit. The y chain did not elicit measurable antibodies in rabbits or mice as evidenced by radioimmunoassay or double immunodiffusion. A sensitive competitive radioimmunoassay was developed in which the B subunit could inhibit binding ofradiolabeled A subunit and a chain with either antisera prepared against A subunit or a chain. Neither the A subunit nor the a chain could inhibit binding of B subunit with the antiserum prepared against B subunit. In addition, selected elution fractions obtained during A-and B-subunit purification were used to immunize groups of mice. Mice responded to immunization with the elution fractions of A subunit by producing anti-A-subunit and anti-B-subunit serum antibody responses, whereas mice immunized with elution fractions of B subunit produced only antibodies specific for the B subunit. An equimolar amount of the two resulting protein peaks was used to immunize two groups of rabbits. Rabbits immunized with A subunit, produced a serum anti-B subunit response equal to that of rabbits immunized with the B subunit. Rabbits immunized with equimolar concentrations of A and B subunits were observed to be equally protected against intestinal loop challenge with Vibrio cholerae Inaba V86. The A subunit, not the B subunit, was biologically active when tested by the S49 mouse lymphosarcoma cell test. These studies provide additional evidence supporting the hypothesis that the A subunit, specifically of a chain, of cholera toxin contains antigenic determinants in common with the B subunit.
27); however, its binding to these cell receptors does not result in the stimulation of adenylate cyclase. It was recently reported that after the toxin binds to the ganglioside GM1 receptor, the A subunit enters the cell and in the presence of nicotinamide adenine dinucleotide ribosylates a guanosine 5'-triphosphate binding protein, the regulatory guanosine triphosphatase of adenylate cyclase, thereby inactivating it (1) .
The amino acid sequence of the ,6 chain has been elucidated (16, 18) , and the first 20 Nterminal residues of the a and y chains have been reported (17) . Amino acid sequencing and amino acid analyses have thus far shown each polypeptide to be unique (16, 17, 22) .
There is limited information about the immunological properties of the A and B subunits of the cholera toxin. Double immunodiffusion analyses have indicated that the toxin contains antigenic determinants in addition to those unique to choleragenoid (B subunit) (11, 23) . These results are consistent with chemical and structural analyses of the subunits. Finkelstein et al. (6) reported that rabbits immunized with purified A subunit consistently produced serum antibodies which precipitated both toxin and the B subunit. These results were interpreted as possible A subunit contamination with the B subunit. Others have reported the same findings; however, no evidence of B subunit contamination was in fact observed (24, 28) . In this report we extend the immunological study of the antigenic determinants of the A and B subunits and a and y chains by using radioimmunoassay (RIA) procedures for each component as well as the S49 mouse lymphosarcoma cell test (26) .
MATERIALS AND METHODS
Cholera toxin purification. Cholera toxin (lot no. 0175) was purified from fermentors inoculated with Vibrio cholerae Inaba 569B as previously described (10, 16 ).
Subunit purification. The A and B subunits were purified from cholera toxin by gel filtration on a BioGel P-60 column eluted with 0.2 M sodium formate buffer, pH 3.5, containing 5.2 M guanidine-hydrochloride (17) . Two different filtration columns were used in this investigation. For rabbit immunization studies, 50 mg of cholera toxin was chromatographed on a column (2.5 by 110 cm), and the peak tubes were dialyzed against 0.01 tris(hydroxymethyl)aminomethane(Tris)-hydrochloride buffer containing 0.2 M NaCl and 0.001 M ethylenediaminetetraacetic acid, pH 7.5 . For mouse and additional rabbit immunization studies, a smaller column (1 by 80 cm) was used to chromatograph 10 mg of cholera toxin. Selected elution fractions were dialyzed against the Tris-hydrochloride buffer previously described.
The a and y chains used for immunization and RIA
were purified from about 80 mg of S-['4C]carbamoylmethylated A subunit by gel filtration on a Bio-Gel P-60 column (2.5 by 110 cm) equilibrated with the formate-guanidine buffer described above. Column eluates were monitored by absorbance at 280 nm and by measurement of radioactivity (100-,ul portions from each fraction). Antiserum preparation. Four groups of five rabbits each were immunized with purified A-subunit, achain, y-chain, or B-subunit preparations emulsified in Freund complete adjuvant. Each rabbit was injected by the intraperitoneal, intramuscular, and subcutaneous routes with a total of 200,ug of the respective antigenic preparation. Blood samples were taken from the rabbits every 3 weeks, and a booster dose of 200 ,ug was administered whenever antibody titers began to decrease, as determined by passive hemagglutination with toxin-sensitized erythrocytes (7) . All sera were stored at -20°C.
Two additional groups of five rabbits each were immunized with the A and B subunits, respectively, without Freund complete adjuvant. Each rabbit was immunized intramuscularly with 8.9 x 10-' ,umol of A (28 ,ug) or B (50 jig) subunit as an initial injection and subsequently given a booster injection of the same equimolar amount of antigen after 4 weeks. Preimmunization, 4-week, and 6-week blood samples were taken from the central ear artery. At 6 weeks, the animals were challenged with live V. cholerae organisms (Inaba V86) by the ligated loop technique as previously described (2) with challenge doses ranging from 103 to 108 organisms per loop.
Selected fractions eluted from the ascending and descending portions of the two protein peaks from the P-60 column after application of a 10-mg sample of cholera toxin were dialyzed against the Tris-hydrochloride buffer. The protein content of each fraction was determined by the method of Lowry et al. (21) . Each fraction was diluted 1:21.5 in Tris-hydrochloride buffer, and 0.5 ml of each dilution was injected by the intraperitoneal route into eleven groups of 15-to 20- RIA. An RIA with polyvinyl chloride microtiter plates was used as previously described (10) . Protein preparations were radiolabeled by the chloramine T method with 125I (10) . After the primary antibody reaction was allowed to proceed for 18 
RESULTS
Subunit and polypeptide chain purification. The P-60 elution profile of the cholera toxin sample is shown in Fig. 1A . The first protein peak eluted was shown by electrophoresis to be A subunit, and the second peak was shown to be chain (17) . The two peak absorbance fractions were dialyzed against tris-hydrochloride buffer and subsequently used for rabbit immunization. Reduced and alkylated A subunit gave an elution pattern as depicted in Fig. 1B , demonstrating separation of the a and y chains. The a chain was present in the first peak, and the y chain was present in the second peak. Although the y chain does not have an appreciable absorbance at 280 nm due to the absence of tryptophan (22) , the eluting peak was observed by monitoring radioactivity of the S-[14C]carbamoylmethyl moiety of the protein resulting from alkylation. The peak tubes were dialyzed against the Tris-hydrochloride buffer and used in gel double immunodiffusion studies and rabbit immunizations. Double immunodiffsion analysis. Consecutive serum samples from rabbits immunized with the A subunit were tested by gel double immunodiffusion for reaction with cholera toxin and its subunits. As illustrated in Fig. 2A tions tested here were elicited by A strong anti-B-subunit response was n tisera prepared against a chain precipil the a-chain and A-subunit preparation
The serum antibody response in rabbits im-A munized with the B subunit produced typical Ouchterlony patterns as shown in Fig. 2B . This pattern illustrated that anti-B subunit sera were monospecific for the B subunit and shared a reaction of identity with toxin. There were no precipitin reactions between A-subunit, a-chain, or -y-chain (y-chain data not shown) and anti-Bsubunit sera. Rabbits immunized with y chain did not produce any detectable antibodies as tested by RIA or double gel diffusion. In addition, the y-chain preparation was not precipitated by any of the other antisera prepared against the other preparations.
Analysis of the antigenic relationship of B:> A and B subunits. Radiolabeled A and radiolabeled B subunits were used to titrate preimmunization as well as 3-and 6-week-post-immunization serum samples from rabbits immunized with 200 1tg of A subunit emulsified in
Freund complete adjuvant. A rising titer was detectable with both radiolabeled A subunit and B subunit (data not shown). Pre-immunization serum samples were incapable of binding radioactivity of the A subunit; however, 50% of the radioactivity was bound at a mean dilution of 1.2 x 103 at 3 weeks and 1.7 x 103 at 6 weeks. The same sera were titrated with radiolabeled B subunit. Preimmunization serum samples did not bind the radiolabeled B subunit; however, 50% of the radioactivity was bound at a mean cal of post-dilution of 5.0 X 103 at 3 weeks and 2.0 x 104 at ed with the 6 weeks. I in Freund A more extensive survey of these anti-A-sub-,olera toxin unit sera was obtained by allowing sera to react chain (a). with radiolabeled toxin, a chain, and y chain, as with any well as radiolabeled A and B subunits. A typical radiolabeled binding pattern of one of these sera is shown in Fig. 3 . Radiolabeled y chain did not nti-A-sub-bind to any of the sera tested. Linear regression ipitin line analysis of each line showed the slope for cholera lt, and a-toxin to be -0.886 (r = 0.95); the B-subunit line it sera did slope was -0.669 (r = 0.88), the A-subunit slope (data not was -0.776 (r = 0.92), and the a-chain slope was by the A -0.717 (r = 0.86). r with the When each of the sera was further studied by entity with competitive inhibition of radiolabeled A subunit line that with unlabeled toxin, A subunit, B subunit, a toxin was chain, and cholera toxin all could inhibit binding Ins of non-of radiolabeled A subunit, indicating cross-reacn and the tivity (Fig. 4) . Linear regression analysis of the nd B-sub-resulting lines showed the A subunit to have a y popula-line slope of -0.32 (r = 0.94), the a chain to have subunit, a a slope of -0.634 (r = 0.97), the toxin line to oted. An To determine whether those cross-reactive sites were located on the a chain, an RIA was performed with antisera to a chain and radiolabeled a chain, A Sera from rabbits immunized with 200 1g of B subunit emulsified in Freund complete adjuvant were titrated with both radiolabeled A and B subunits. Neither the pre-immunization nor the 3-or 6-week-post-immunization sera reacted by binding radiolabeled A subunit. A mean rising titer was obtained with the radiolabeled B subunit in which 50% of the radioactivity was bound at a 5.0 x 103 dilution at 3 weeks and a 2.8 x 104 dilution at 6 weeks, whereas no detectable titer was seen with pre-immunization sera (data not shown).
Serum samples from three representative rabbits immunized with B subunit were further analyzed with radiolabeled toxin, a chain, and y chain, as well as with radiolabeled A and B subunits. The typical radiolabeled binding pattern of an anti-B-subunit serum is depicted in Fig. 6 . Radiolabeled toxin and B subunit were Figure 7 shows the crossreactive analysis of a typical anti-B-subunit serum. The anti-B-subunit serum tested was previously titrated and diluted for 50% binding of the radioactivity added of radiolabeled B subunit. Increasing concentrations of unlabeled toxin and its components were allowed to compete for anti-B-subunit antibody binding sites in the presence of radiolabeled B subunit. Figure 7 indicates that radiolabeled B subunit could be completely inhibited from binding to anti-B-subunit sera by toxin and B subunit. Concentrations of up to 1.0 x 10-2, 3.0 x 10-2, and 1.55 x 10-3 /Amol of A subunit, a chain, and y chain, respectively, per ml were noninhibitory. Linear regression analysis of the percentages of radioactivity inhibited by increasing concentrations of unlabeled toxin indicated line slopes of -0.960 (r = 0.91), -1.014 (r = 0.84), and -1.128 (r = 0.92), with 50% inhibition occurring at concentrations of 2.3 x 10-7 3.1 x 10-7, and 3.6 x 10-7 ,mol/ml, respectively. Similar line slopes of -1.019 (r = 0.92), -0.967 (r = 0.91), and -1.034 (r = 0.85) occurred with unlabeled B subunit, in which 50% inhibitions occurred with concentrations of 1.05 X 10-7, 1.25 X 10-7, and 1.9 x 10-7 ,umol of B subunit per ml, respectively.
Mouse inoculation study with column fractions from A and B subunit purification. Selected fractions from the ascending and descending protein peaks of the smaller Bio-Gel P-60 column used to fractionate 10 mg of cholera toxin were used for mouse inoculation (Fig. 8) . This separation allowed for purification of the A subunit (fraction volumes 14 to 22) and B sub- unit (fraction volumes 24 to 36). Mouse groups were inoculated with proportionate amounts of antigen from the selected fractions based upon Lowry protein measurements as indicated in Table 1 . Titration of all mouse sera with radiolabeled A subunit (see Fig. 9 ) indicated that preinoculation and 3-week-post-inoculation bleedings did not bind any radioactivity; however, 6-week bleedings showed geometric mean titers of 9 . RIA of mice sera at the 3-week (0) and 4-week (0) bleedings with radiolabeled B subunit ( ).
Only the 4-week bleedings (L) could be titrated by radiolabeled A subunit (---).
2.6 and 6.4 and 4.0 AU/ml which were limited to mice inoculated with elution volumes 16, 18, and 20, respectively. Titrations of all these sera with radiolabeled B subunit are also shown in Fig. 9 . Although pre-immunization sera did not bind any radiolabeled B subunit, an increase in serum anti-B-subunit titer was seen between 3-and 6-week-post-inoculation bleedings in all mouse groups. The highest geometric mean antitoxin titer of 29.8 AU/ml was found with the mouse group inoculated with elution volume 28. The height of antibody responses in each mouse group at 6 weeks closely followed the respective proportionate amount of protein antigen administered (see Table 1 ). However, an important observation, illustrated in Fig. 9 , was that radiolabeled B subunit not only detected antibody responses in mouse groups immunized with Bsubunit eluates (elution volumes 25 to 35), but also detected antibody responses in mouse groups immunized with A-subunit eluates (elution volumes 14 to 21). Serological responses of rabbits immunized with A and B subunits. Pre-immunization, 4-week, and 6-week serum samples from rabbits immunized with 8 .92 x 10-4 11mol of either A or B subunit (elution volume 18 or 31, respectively) in which a booster immunization, consisting of the same respective amount of antigen per rabbit, was given at 4 weeks, were each titrated with radiolabeled A and B subunits. No antibody titers were detectable in any pre-immunization sera with either radiolabeled subunit. However, rabbits immunized with A subunit, when titrated with radiolabeled A subunit, produced a geometric mean antibody titer of 2.5 AU/ml at 4 weeks. A subsequent booster immunization at 4 weeks produced a much higher anamnestic-type antibody response with a geometric mean titer of 2,528 AU/ml (Fig. 10 ). Rabbits immunized with B subunit did not produce detectable antibody responses when titrated with radiolabeled A subunit. In comparison, when each of the antisera was titrated with radiolabeled B subunit, geometric mean antibody titers of 1.8 for the A rabbits and 10.8 AU/ ml for the B subunit were noted at 4 weeks. After a subsequent booster immunization at 4 weeks, these titers increased to 64.2 and 112.2 AU/ml at 6 weeks, respectively.
Rabbit intestinal loop challenge. Rabbit groups immunized with equimolar concentrations of either A or B subunit eluted from the Bio-Gel P-60 column were challenged with V. cholerae Inaba V-86 organisms by the intestinal loop method (Fig. 11) . The mean loop responses for rabbits immunized previously with the A subunit were slightly lower than those of rabbits receiving an equal molar concentration of B subunit as immunogen, indicating less fluid accumulation in the loops or better protection. However, these responses were not significantly different when compared by the analysis of variance (F test). for the antigenic determinants of cholera toxin and suggested that the A and B subunits composing cholera toxin shared some antigenic determinants (10). This hypothesis was based on the observation that unlabeled A subunit competed with radiolabeled B subunit for antitoxin binding sites. Similarly, unlabeled B subunit competed with radiolabeled A subunit for antitoxin binding sites. Experiments presented here further suggest that the A subunit and, more specifically, the a chain possess antigenic determinants that are common to the B subunit. Antisera produced against each of the purified toxin components were initially tested in Ouchterlony double-immunodiffusion plates. Results of this test indicated that antiserum prepared against purified A subunit not only precipitated the a chain, but also precipitated the B subunit, and antisera prepared against B subunit only precipitated B subunit.
Based on the assumptions that the amount of contaminating B subunit is negligible and that the sensitivity of the Ouchterlony test might not detect this contamination, RIA methods were developed for the measurement of A subunit, B subunit, and a chain in our purified preparations. Each of the above antisera were first titrated with each of the radiolabeled proteins. Interestingly, the antisera produced against A subunit precipitated radiolabeled A subunit, a chain, and B subunit; however, the antisera to B subunit would only precipitate the radiolabeled B subunit. These observations paralleled what we had observed in the Ouchterlony tests. We had expected that this methodology would have detected some precipitation of the radiolabeled A subunit with B-subunit antisera. Even if low dilutions of B subunit antiserum (1:10) were tested, no radioactivity was precipitated with either the radiolabeled A subunit or radiolabeled a chain.
More extensive studies of these antisera were performed to evaluate and define possible antigenic cross-reactivity between the A and B subunits. A competitive RIA system was developed for each antiserum in which radiolabeled components competed with unlabeled components for antibody binding sites. When radiolabeled A subunit was used to compete with each of the other unlabeled components for antibody binding sites to the A subunit, the B subunit was capable of inhibiting the binding by 50% of the radiolabeled A subunit at concentrations (in micromoles per milliliter) 1/100 of the control A subunit. At higher concentrations the B subunit was able to completely inhibit radiolabeled A- VOL. 25, 1979 on December 15, 2017 by guest http://iai.asm.org/ Downloaded from subunit binding. The slopes of the B-subunit line and toxin line were similar, suggesting similar antigenic binding sites competing with radiolabeled A subunit. It was surprising to observe that the A subunit was capable of inhibiting radiolabel binding at concentrations from 10-3 to 10-7 /mol/ml in the test. This observation was thought to be due to the fact that at higher concentrations the A subunit aggregates, thereby burying many of the antigenic sites. As the A subunit is diluted, the aggregated subunits disperse, exposing more antigenic sites to bind antibody. This aggregation has been observed when testing different dilutions of A subunit by Ouchterlony (data not shown). The higher-concentration samples precipitate as a broad diffuse band composed of several lines, whereas diluted samples precipitate as much sharper lines. When radiolabeled a chain was used to compete with each of the other unlabeled components for antibody binding to the a chain, complete inhibition of radiolabel binding was found with increasing concentrations of a chain. Unlabeled B subunit was capable of inhibiting binding of about 27% of the radioactivity. The achain antisera neither precipitated the B subunit in the Ouchterlony experiments nor bound radiolabeled B subunit, thus exemplifying the sensitivity of this competitive assay. The inability of unlabeled toxin to inhibit more than 15% of the radiolabel indicates that the a-chain antigenic sites are buried within the toxin molecule and are unavailable for antibody binding. This is substantiated by the fact that anti-a-chain sera do not neutralize cholera toxin when analyzed by the permeability factor neutralization test (25) .
Contrary to what would have been expected in the competitive RIA with B-subunit antisera and radiolabeled B subunit, only the toxin and B subunit inhibited the radiolabel binding. The B subunit antiserum was monospecific for only the B subunit. The results of these conflicting competitive inhibition assays suggested the possibility that the a chain and , / chain may contain regions of chemical similarity. Perhaps the antibodies raised against the A subunit and a chain were more directed to amino acid sequence, whereas antibodies to the B subunit were against structural conformation. This might explain why the antisera to A subunit and a chain precipitate B subunit, but antibodies against the B subunit precipitate only the B subunit. One other possibility was that the B subunit in the competitive assays was binding to the radiolabels such that the radiolabels were unable to bind antibody, thereby producing erroneous competitive results. This was ruled out as a possibility by performing an assay with radiolabeled a chain or A subunit with unlabeled B subunit followed by the addition of B-subunit antiserum. None of the radioactivity was precipitated (data not shown). The possibility that the A-subunit and a-chain preparations were contaminated with B subunit was still a concern since perhaps the amount of contamination was so small that we were unable to detect it by this assay. To continue characterization of the immunological and functional properties of the molecule, additional antigenic and biological experiments were performed.
Mice immunized with different eluted fractions obtained from gel filtration of the A and B subunits elicited serum antibody titers which were titrated by their respective radiolabel. The A-subunit fraction antisera, when titrated with radiolabeled A subunit, showed a peak antitoxin titer corresponding to the peak protein fraction of the A subunit (fraction number 18). The peak antitoxin titer response of the B-subunit fractions was with fraction number 28 rather than the protein peak fraction number 31. Either this may represent the animal's peak immunological response to an antigen at concentrations greater than 14.7 ,tg, or possibly this may be simply due to dilution error in the experiment.
Each of the A subunit mice antisera was then titrated with radiolabel B subunit, and again we observed cross-reactivity. Interestingly, though, there was a shift of the peak B-antitoxin titer response from the peak A-subunit protein fraction number 18 to fraction number 21 which was on the descending portion of the elution curve. These findings were suggestive of a possible /3-chain complex, possibly a dimer, with a molecular weight of about 22,000 which might have eluted at this particular fraction; however, when this fraction was tested in a competitive RIA with B-subunit antiserum and radiolabeled B subunit, no competition was observed. Thus, the data would argue against the presence of,8-chain dimers. Interestingly, all of the fractions under the A-subunit curve were able to elicit this crossreactive antibody. If contamination of the A subunit with B subunit was a viable explanation of this observed cross-reactivity, one would expect that the competitive RIA with B subunit would demonstrate its presence or the peak antibody response would be on ascending portion of the A-subunit protein elution peak and not on the descending portion since the molecular weight of the combined polypeptide chains would be greater than the molecular weight of the A subunit.
The antisera prepared against the B-subunit fraction failed to cross-react with the radiola- Biological activity of the different elution fractions as assayed by the mouse lymphosarcoma cell system indicated that the A subunit by itself does have biological activity. Biological activity of the A subunit in different systems has been observed by others (3, 23, 26) . The ability of the A subunit to elicit biological activity was about 1/10,000 on a molar level to that of intact toxin. This makes the A subunit a much less effective agent of biological activity in a whole cell system than intact toxin. The B subunit, on the other hand, did not have biological activity which was demonstrable in this system.
Rabbits immunized with equimolar concentrations of A and B subunits responded by producing serum antibodies with similar specificities to that of the mice study. We were able to detect a rising titer to both the A and B subunits in rabbits immunized with the A subunit. Furthermore, at 6 weeks after immunization the Asubunit-immunized rabbits possessed an anti-Bsubunit response comparable to those rabbits immunized with B subunit at 6 weeks after immunization. Antibodies specific for the A subunit were not detected in rabbits immunized with the B subunit by using radiolabeled A subunit in the RIA. It was interesting that rabbits immunized with the A subunit, in comparison with rabbits immunized with an equimolar concentration of B subunit, were similarly protected during challenge, even the titrations by RIA indicated a titer which was comparable to that obtained in rabbits immunized with the B subunit. This might indicate that antibody directed against the B subunit determinants may be the antibodies responsible for toxin neutralization in vivo. This is a plausible explanation because recently we have shown that antisera specific for the B subunit effectively neutralize the skin permeability of the toxin. In contrast, antisera to the a chain of the A subunit and to the A subunit (absorbed with B subunit) react with the A subunit but do not neutralize skin permeability activity of the toxin (26) .
In this report we present three additional competitive RIAs for studying the antigenic characteristics of cholera toxin. We have provided further evidence for the possible antigenic relatedness between the A and B subunits, specifically between the a chain and the B subunit. We have been unable to detect B-subunit contamination in the A-subunit or a-chain preparations. In fact, all fractions of the A subunit obtained by gel filtration of cholera toxin in the presence of guanidine elicited antibodies which were able CHOLERA TOXIN SUBUNITS 625 to bind radiolabeled B subunit in RIA. In addition we have also reported that rabbits immunized with A subunit were equally protected when challenged with live vibrios as those immunized with equimolar amounts of B subunit. In biological testing, the A subunit but not B subunit, a chain, or -y chain, was found to have biological activity when tested in the mouse lymphosarcoma cell system. Lastly, the y chain was nonantigenic and nonreactive in all immunological testing.
